Chronic Myeloid Leukemia Patient Registry in the Russian Federation: From Observational Studies to the Efficacy Evaluation in Clinical Practice

Chronic Myeloid Leukemia Patient Registry in the Russian Federation: From Observational Studies to the Efficacy Evaluation in Clinical Practice

Background. Due to the significant increase in life expectancy and the quality of life in patients with chronic myeloid leukemia (CML) as well as the growing need for expensive tyrosine kinase inhibitors (TKI), the analysis of cost-effectiveness and lifelong monitoring of patients is especially impo...

Full description

Bibliographic Details
Main Authors: AG Turkina, NV Novitskaya, AK Golenkov, VA Shuvaev, LI Napso, V Krylova, AM Savrilova, GSh Safuanova, AV Korobkin, TYu Klitochenko, EV Burnasheva, EV Vasil’ev, OM Senderova, EYu Fedorova, LM Yalunina, EK Nekhai, GB Kuchma, AS Lyamkina, NG Shchedrova
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2017-07-01
Series:Kliničeskaâ onkogematologiâ
Subjects:
chronic myeloid leukemia
registry
tyrosine kinase inhibitors
imatinib
nilotinib
quality of medical care
Online Access:http://bloodjournal.ru/wp-content/uploads/2017/09/12.pdf

Internet

http://bloodjournal.ru/wp-content/uploads/2017/09/12.pdf

Similar Items